Database : HANSEN Search on : LEVAMISOL/ADMIN [Subject descriptor] References found : 3 [refine] Displaying: 1 .. 3   in format [Detailed]

page 1 de 1

1 / 3

HANSEN

select to print

Id: 13871 Author: Shepard, C. C; Van Landingham, R; Walker, L. L Title: Effect of levamisole on Mycobacterium leprae in mice ..- Source: s.l; s.n; may 1977. 4 p. graf. Descriptors: ADMINISTRACAO ORAL VACINA BCG INJECOES SUBCUTÂNEAS HANSENIASE/imunol LEVAMISOL/admin LEVAMISOL/farmacol MYCOBACTERIUM LEPRAE/ef drogas MYCOBACTERIUM LEPRAE/cresc Limits: ANIMAL CAMUNDONGOS SUPPORT, U.S. GOV'T, P.H.S. Electronic Medium: http://www.ilsl.br Location: BR191.1; 00596/s

2 / 3

HANSEN

select to print

Id: 13520 Author: Meyers, Wayne M; Kvernes, Staffan; Staple, Edna M Title: Failure of levamisole to alter the lepromin reaction ..- Source: s.l; s.n; sep. 1975. 3 p. tab. Abstract: In a study of 37 leprosy patients, the oral administration of levamisole failed to provoke an increase in both the Fernandez and Mitsuda reactions to lepromins of human and armadillo origin. We interpret this as evidence against an effective specific immunostimulatory capability of levamisole in leprosy patients under the conditions of the study. Current knowledge of the mechanism of levamisole action supports the concept that the fundamental immunologic defect in lepromatosus leprosy may reside in the lymphocyte and not the macrophage, or the respective related functions of these two cell forms.(AU). Descriptors: LINFOCITOS/imunol MYCOBACTERIUM LEPRAE/isol LEVAMISOL/admin LEVAMISOL/farmacol HANSENIASE/imunol ANTIGENO DE MITSUDA/imunol IMUNIDADE CELULAR/ef drogas TATUS Limits: HUMANO ANIMAL ADULTO MEIA-IDADE IDOSO CAMUNDONGOS SUPPORT, U.S. GOV'T, NON-P.H.S. Electronic Medium: http://www.ilsl.br Location: BR191.1; 01921/s

3 / 3

HANSEN

select to print

Id: 13191 Author: Shepard, C. C; Van Landingham, R; Walker, L. L Title: Effect of levamisole on Mycobacterium leprae in mice ..- Source: s.l; s.n; may 1977. 14 p. tab, graf. Abstract: Levamisole, an antihelminthic drug that is capable of enhancing immune responses in mice and in humans, was tested in experimental Mycobacterium leprae infections in mice by a number of schedules. Intermittent schedules were used, and administration of the drug was started (i) around the time of inoculation with M. leprae, (ii) when the M. leprae population was approaching the plateau level, (iii) after the onset of the plateau phase, or (iv) after BCG vaccination 28 days following the inoculation with M. leprae. No effect of drug could be discerned with any of the schedules.(AU). Descriptors: MYCOBACTERIUM LEPRAE/ef drogas MYCOBACTERIUM LEPRAE/cresc LEVAMISOL/admin LEVAMISOL/farmacol HANSENIASE/imunol INJECOES SUBCUTÂNEAS VACINA BCG ADMINISTRACAO ORAL Limits: ANIMAL CAMUNDONGOS SUPPORT, U.S. GOV'T, P.H.S. Electronic Medium: http://www.ilsl.br Location: BR191.1; 00596/s

---

page 1 de 1

Refine the search

Database : HANSEN

Advanced form

Search for : Free form

		Search	in field
1			WordsTitle wordsAbstract wordsAuthorInstitutional authorSubject descriptorLimitsLanguageCountry, year publicationJournalType of literatureBibliographic levelMonography in seriesPublication typeConferenceUnique identifierLocationElectronic supportEntry dateRecord type
2	and or and not		WordsTitle wordsAbstract wordsAuthorInstitutional authorSubject descriptorLimitsLanguageCountry, year publicationJournalType of literatureBibliographic levelMonography in seriesPublication typeConferenceUnique identifierLocationElectronic supportEntry dateRecord type
3	and or and not		WordsTitle wordsAbstract wordsAuthorInstitutional authorSubject descriptorLimitsLanguageCountry, year publicationJournalType of literatureBibliographic levelMonography in seriesPublication typeConferenceUnique identifierLocationElectronic supportEntry dateRecord type

Search engine: iAH powered by WWWISIS

IAH - © BIREME/PAHO/WHO Latin American and Caribbean Center on Health Sciences Information